• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性前列腺切除术后的生化复发和前列腺癌中的 miR-200a 水平。

Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer.

机构信息

National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.

出版信息

Prostate. 2012 Aug 1;72(11):1193-9. doi: 10.1002/pros.22469. Epub 2011 Dec 7.

DOI:10.1002/pros.22469
PMID:22161972
Abstract

BACKGROUND

Radical prostatectomy cures the majority of men with clinically localized disease, but up to 30% of men relapse with rising serum PSA levels. Stage, Gleason grade, and pre-operative PSA levels are associated with outcome but do not accurately predict which individuals will relapse. MicroRNA (miRNA) levels are altered in cancer and are associated with progression of disease. The miR-200 family has roles in prostate cancer.

METHODS

miR-200a levels were measured in 18 radical prostatectomy samples from men who did not relapse and from 18 who did relapse, matched for stage (all T3), grade, and PSA levels. A pair of cancer and normal prostate cell lines derived from the same radical prostatectomy specimen were transfected with miR-200a to determine the effects on growth, wound healing, and invasion.

RESULTS

Comparing the matched samples, 11 of the relapsers contained lower, 2 higher and 5 similar levels to the non-relapsers. Transient transfection of miR-200a significantly reduced cell proliferation in prostate cancer cell lines but did not affect invasiveness.

CONCLUSION

miR-200a overexpression reduced prostate cancer cell growth and may have potential, in combination with other markers, in stratifying prostate cancer patients for more intensive monitoring and therapy.

摘要

背景

根治性前列腺切除术治愈了大多数患有临床局限性疾病的男性,但多达 30%的男性因血清 PSA 水平升高而复发。分期、Gleason 分级和术前 PSA 水平与预后相关,但不能准确预测哪些患者会复发。miRNA(miRNA)水平在癌症中发生改变,并与疾病的进展相关。miR-200 家族在前列腺癌中具有作用。

方法

在 18 例无复发和 18 例复发的接受根治性前列腺切除术的男性的前列腺组织样本中测量了 miR-200a 的水平,这些患者的分期(均为 T3)、分级和 PSA 水平相匹配。从同一例根治性前列腺切除术标本中获得的一对癌细胞和正常前列腺细胞系用 miR-200a 转染,以确定对生长、伤口愈合和侵袭的影响。

结果

比较匹配的样本,11 例复发者的 miR-200a 水平低于非复发者,2 例高于非复发者,5 例与非复发者相似。miR-200a 的瞬时转染显著降低了前列腺癌细胞系的增殖,但不影响侵袭性。

结论

miR-200a 的过表达降低了前列腺癌细胞的生长,并且可能与其他标志物一起,在对前列腺癌患者进行更强化的监测和治疗方面具有潜力。

相似文献

1
Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer.根治性前列腺切除术后的生化复发和前列腺癌中的 miR-200a 水平。
Prostate. 2012 Aug 1;72(11):1193-9. doi: 10.1002/pros.22469. Epub 2011 Dec 7.
2
Should we replace the Gleason score with the amount of high-grade prostate cancer?我们是否应该用高级别前列腺癌的数量来取代 Gleason 评分?
Eur Urol. 2007 Apr;51(4):931-9. doi: 10.1016/j.eururo.2006.07.051. Epub 2006 Aug 15.
3
Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.临床局限性前列腺癌单纯根治性前列腺切除术后临床及病理因素与前列腺特异性抗原水平升高的相关性
Urology. 1996 Aug;48(2):249-60. doi: 10.1016/S0090-4295(96)00167-7.
4
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.辅助治疗初治患者根治性前列腺切除术后切缘阳性对前列腺特异抗原失败的影响。
BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.
5
Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.术前游离前列腺特异抗原百分比可预测总前列腺特异抗原水平低于10 ng/ml的接受根治性前列腺切除术患者的临床结局。
Eur Urol. 2006 Feb;49(2):293-302. doi: 10.1016/j.eururo.2005.10.027. Epub 2005 Dec 20.
6
Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.通过超敏检测法测得的血清前列腺特异性抗原最低点值作为临床局限性前列腺癌根治性前列腺切除术后生化复发预测指标的实用性。
Urol Int. 2006;76(3):227-31. doi: 10.1159/000091624.
7
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.术前血清小窝蛋白-1作为根治性前列腺切除术队列中复发的预后标志物。
Clin Cancer Res. 2006 Aug 15;12(16):4872-5. doi: 10.1158/1078-0432.CCR-06-0417.
8
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.临床局限性前列腺癌根治性前列腺切除术后的生化(前列腺特异性抗原)复发概率。
J Urol. 2003 Feb;169(2):517-23. doi: 10.1097/01.ju.0000045749.90353.c7.
9
Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer.对于手术Gleason评分6分及以下的前列腺癌患者,肿瘤体积不能预测根治性前列腺切除术后的生化复发情况。
Urology. 2007 Aug;70(2):294-8. doi: 10.1016/j.urology.2007.03.062.
10
External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.临床分期为T1-2期前列腺癌的体外放射治疗与根治性前列腺切除术:根据治疗前前列腺特异性抗原(PSA)水平和活检Gleason评分分层的治疗意义
Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87.

引用本文的文献

1
Impact of UV-Irradiated Mesoporous Titania Nanoparticles (mTiNPs) on Key Onco- and Tumor Suppressor microRNAs of PC3 Prostate Cancer Cells.紫外线照射的介孔二氧化钛纳米颗粒(mTiNPs)对PC3前列腺癌细胞关键致癌和抑癌微小RNA的影响
Genes (Basel). 2025 Jan 25;16(2):148. doi: 10.3390/genes16020148.
2
Recent progress in microRNA research for prostate cancer.前列腺癌微小RNA研究的最新进展
Discov Oncol. 2024 Sep 27;15(1):480. doi: 10.1007/s12672-024-01376-4.
3
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.
关于前列腺癌中程序性死亡受体配体1(PD-L1)表达我们需要了解什么?一项系统文献综述。第5部分:PD-L1的表观遗传调控
Int J Mol Sci. 2021 Nov 15;22(22):12314. doi: 10.3390/ijms222212314.
4
Differential expression of miRNAs and functional role of mir-200a in high and low productivity CHO cells expressing an Fc fusion protein.差异表达的 miRNAs 和 mir-200a 在高和低表达 Fc 融合蛋白的 CHO 细胞中的功能作用。
Biotechnol Lett. 2021 Aug;43(8):1551-1563. doi: 10.1007/s10529-021-03153-7. Epub 2021 Jun 16.
5
The Influence of Radical Prostatectomy on the Expression of Cell-Free MiRNA.根治性前列腺切除术对游离微小RNA表达的影响
Diagnostics (Basel). 2020 Aug 17;10(8):600. doi: 10.3390/diagnostics10080600.
6
MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.MicroRNA-200a 通过 BRD4/AR 信号通路抑制前列腺癌进展。
Cancer Med. 2019 Apr;8(4):1474-1485. doi: 10.1002/cam4.2029. Epub 2019 Feb 19.
7
Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells.核糖核酸酶MCPiP1导致胰腺癌细胞中微小RNA-200家族成员缺失。
Oncotarget. 2018 Nov 13;9(89):35941-35961. doi: 10.18632/oncotarget.26310.
8
Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs.一组耐辐射前列腺癌细胞的分析鉴定出关键微小RNA的失调。
Clin Transl Radiat Oncol. 2017 Feb 17;2:63-68. doi: 10.1016/j.ctro.2017.01.005. eCollection 2017 Feb.
9
MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.微小 RNA 介导的人肝细胞癌中高迁移率族蛋白 B1 的调控。
Biomed Res Int. 2018 Jan 31;2018:2754941. doi: 10.1155/2018/2754941. eCollection 2018.
10
Molecular and cellular mechanisms of castration resistant prostate cancer.去势抵抗性前列腺癌的分子和细胞机制
Oncol Lett. 2018 May;15(5):6063-6076. doi: 10.3892/ol.2018.8123. Epub 2018 Feb 27.